Comment on: Intravenous ferric carboxymaltose for iron deficiency anemia or iron deficiency without anemia after poor response to oral iron treatment: Benefits and risks in a cohort of 144 children and adolescents

Pediatr Blood Cancer. 2021 Mar;68(3):e28726. doi: 10.1002/pbc.28726. Epub 2020 Sep 23.

¹ Pediatric Hematology Division, University Children's Hospital of Zurich, Zurich, Switzerland.
² Pediatric Hematology-Oncology Unit, Division of Pediatrics, University Hospital of Geneva, Geneva, Switzerland.
³ Pediatric Hematology-Oncology Unit, Children's Hospital of Sankt Gallen, St. Gallen, Switzerland.
⁴ Pediatric Hematology-Oncology Department, University Children's Hospital and University of Basel, Basel, Switzerland.
⁵ Division of Pediatrics, Department "Woman-Mother-Child,", Pediatric Hematology-Oncology Unit, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

No abstract available

Publication types